Pricing Log in Create free account

PMGC Holdings Inc. (ELAB) vs Matinas Biopharma Holdings, Inc. (MTNB)

PMGC Holdings Inc. and Matinas Biopharma Holdings, Inc. are both Biotechnology companies. PMGC Holdings Inc. is the larger, with a market value of $1.3M against $1.1M — 1.2× the size. Matinas Biopharma Holdings, Inc. grew revenue faster over the last twelve months: 2,135.9% against 5.41%. Matinas Biopharma Holdings, Inc. has the higher net margin (0.00% vs −523.0%) and the lower return on invested capital (−419.3% vs 0.00%). Across the 18 metrics below, PMGC Holdings Inc. leads on 9 and Matinas Biopharma Holdings, Inc. on 9.

Valuation

Metric ELAB MTNB Biotechnology median
P/E n/m n/m 10.60
P/S 0.31 0.12 9.40
P/B 0.05 0.30 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 1.58 0.04 0.66
EV/Sales (6.87) (0.06) 9.02
Earnings yield (127,538.28%) (1,403.30%) (32.88%)
Free cash flow yield (1,131.30%) (1,142.24%) (23.13%)

Profitability

Metric ELAB MTNB Biotechnology median
Gross margin 31.08% 0.00% 68.51%
Operating margin (458.63%) 0.00% 0.00%
Net margin (522.99%) 0.00% 0.00%
Free cash flow margin (348.69%) 0.00% 0.00%
Return on equity (104.60%) (154.28%) (51.96%)
Return on assets (58.71%) (98.53%) (46.06%)
Return on invested capital 0.00% (419.27%) 0.00%

Growth

Metric ELAB MTNB Biotechnology median
Revenue growth (TTM) 5.41% 2,135.91% 6.76%
EPS growth (last fiscal year) 94.22% 59.84% 29.88%
Revenue growth, 5-year CAGR — 55.69% 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric ELAB MTNB Biotechnology median
Debt to equity 0.02 0.00 0.00
Current ratio 1.36 0.85 4.97
Net debt to EBITDA 0.87 0.62 1.01

Dividend

Metric ELAB MTNB Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ELAB MTNB Biotechnology median
Market cap 1.33m 1.14m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack